Abstract:BACKGROUND: Increased evidence has indicated that the tumour microenvironment plays an essential in the development, treatment and prognosis of head and neck squamous cell carcinoma (HNSC). Recent studies have indicated CC chemokine receptor 4 (CCR4) plays an essential role in tumor invasion and other adverse biological behavior. This study used data from the Cancer Genome Atlas (TCGA) database to explore the role of CCR4 in HNSC and its clinical significance.METHODS: The gene expression and clinical data of HNSC patients in the TCGA database were extracted. Gene Expression Profiling Interactive Analysis (GEPIA) was used to analyze the expression of CCR4 in tumor and non-tumor tissue. Kaplan-Meier survival analysis was used to analyze the relationship between CCR4 expression and overall survival rate (OS), disease-specific survival (DSS), and progression-free interval (PFI) in HNSC. A logistic regression model was used to analyze the relationships between various clinical factors and CCR4 expression. Gene Set Enrichment Analysis (GSEA) was used to explore the potential role of CCR4 in HNSC. Additionally, we explored the relationship between CCR4 and immune infiltration.RESULTS: The expression of CCR4 in HNSC was not significantly different from that in normal tissue. The expression level of CCR4 in wild-type TP53 was higher than that in mutant TP53. Cox regression analysis showed the expression level of CCR4 was related to the patient's tumor grade and Tumor-Node-Metastasis (TNM) stage. CCR4 expression level is an independent prognostic factor. CCR4 is positively correlated with immune infiltration and immune checkpoints expression levels. The results of GSEA revealed that the high CCR4 expression group genes were enriched in allograft rejection, inflammatory response, IL-6/JAK/STAT3 signaling, interferon gamma response, and KRAS signaling up. Low CCR4 expression group genes were enriched in oxidative phosphorylation, MYC targets v1, DNA repair, reactive oxygen species pathway, and P53 pathway. Further, our study indicated CCR4 can also predict the prognosis of radiotherapy patients.CONCLUSIONS: Our study found that CCR4 was a prognostic marker related to HNSC immune infiltration, and patients with high expression of CCR4 had a better prognosis.

ECRG4 Inhibits Growth and Invasiveness of Squamous Cell Carcinoma of the Head and Neck in Vitro and in Vivo

The tumor-promoting function of ECRG4 in papillary thyroid carcinoma and its related mechanism

ECRG4 Acts As a Tumor Suppressor Gene Frequently Hypermethylated in Human Breast Cancer.

ECRG4 As a Novel Tumor Suppressor Gene Inhibits Colorectal Cancer Cell Growth in Vitro and in Vivo

[Expression and Function of ECRG4 in Hepatocellular Carcinoma].

CRMP4 Suppresses Cervical Cancer Cell Proliferation and EMT Through the Wnt/β-catenin Pathway

ECRG4 acts as a tumor suppressor and as a determinant of chemotherapy resistance in human nasopharyngeal carcinoma

Expression of ECRG4, a Novel Esophageal Cancer-Related Gene, Downregulated by CpG Island Hypermethylation in Human Esophageal Squamous Cell Carcinoma

Downregulation of EphA2 expression suppresses the growth and metastasis in squamous-cell carcinoma of the head and neck in vitro and in vivo

CCR4 is a prognostic biomarker and correlated with immune infiltrates in head and neck squamous cell carcinoma

Overexpression of ECRG4 Enhances Chemosensitivity to 5-Fluorouracil in the Human Gastric Cancer SGC-7901 Cell Line

Downregulated ECRG4 is Correlated with Lymph Node Metastasis and Predicts Poor Outcome for Nasopharyngeal Carcinoma Patients

Down-regulation of ECRG4, a candidate tumor suppressor gene, in human breast cancer

ECRG4 Represses Cell Proliferation and Invasiveness via NFIC/OGN/NF-κB Signaling Pathway in Bladder Cancer

Inhibitor of Growth 4 Suppresses Colorectal Cancer Growth and Invasion by Inducing G1 Arrest, Inhibiting Tumor Angiogenesis and Reversing Epithelial-Mesenchymal Transition

Downregulated ECRG4 is Associated with Poor Prognosis in Renal Cell Cancer and is Regulated by Promoter DNA Methylation

RHCG Suppresses Tumorigenicity and Metastasis in Esophageal Squamous Cell Carcinoma via Inhibiting NF-κB Signaling and MMP1 Expression.

[Epha2 Promotes Angiogenesis and Metastasis of Head and Neck Squamous Cell Carcinoma in Vivo].

Expression and Epigenetic Silencing of Ecrg4 Gene in Breast Cancer

Regulator of G-protein signaling 4: a novel tumor suppressor with prognostic significance in non-small cell lung cancer.

E2F4 transcription factor is a prognostic biomarker related to immune infiltration of head and neck squamous cell carcinoma